Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
InnovationA helpful guide for those who want to start a virtual assistant business, including effective virtual assistant business tools to help your new business thrive.
LegalIn recent years following the pandemic, the average length of time to obtain a Grant of Probate has risen significantly. Probate has been known to take up to 16 weeks following submission of an application, with delays as long as 24 weeks in complex estates, o
FinancePhysical contact is the primary culprit behind the unmitigated spread of COVID-19, also known as the novel coronavirus. This is why authorities all over the world are scrambling to lessen overall person-to-person contact in people’s day-to-day interactions.
StrategyWhen choosing what profession to pursue, starting salary will be a big consideration for many people.
InnovationVersatility, flexibility and a broad range of products and services ensure cost effective purchase and quality services in a challenging business environment.
StrategyAs an employee, you spend a significant portion of your life in the workplace. You may think it's just a place where you report for work, time in, eat meals, attend meetings, and time out at the end of the day. But there’s more to it than just a cubicle.
NewsBrand impersonation attacks target an organization’s customers, using their trustworthy identity to fool people into giving away money or sensitive information. However, they also affect the businesses they impersonate. Failing to stop or respond to these in
FinanceAccording to insight from the Office for National Statistics (ONS), more than 38% of the UK workforce now enjoy either a part-hybrid or totally remote role. While sceptics have suggested that this trend will begin to fall in-line with retreating COVID-19 cases
NewsToday’s text-to-speech (TTS) technology has made huge leaps in years, from Wolfgang von Kempelen’s “Speaking Machine” discovery until the advent of AI around the 2000s. Its capacity to store loads of voices, human speech patterns, and a
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
